Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SELLAS Life Sciences Group (SLS) Non-Current Deferred Tax Liability: 2019-2021

Historic Non-Current Deferred Tax Liability for SELLAS Life Sciences Group (SLS) over the last 3 years, with Dec 2021 value amounting to $152,000.

  • SELLAS Life Sciences Group's Non-Current Deferred Tax Liability fell 89.03% to $152,000 in Q4 2021 from the same period last year, while for Dec 2021 it was $152,000, marking a year-over-year decrease of 89.03%. This contributed to the annual value of $152,000 for FY2021, which is 89.03% down from last year.
  • Per SELLAS Life Sciences Group's latest filing, its Non-Current Deferred Tax Liability stood at $152,000 for Q4 2021, which was down 36.40% from $239,000 recorded in Q3 2021.
  • In the past 5 years, SELLAS Life Sciences Group's Non-Current Deferred Tax Liability registered a high of $1.4 million during Q4 2020, and its lowest value of $152,000 during Q4 2021.
  • In the last 3 years, SELLAS Life Sciences Group's Non-Current Deferred Tax Liability had a median value of $262,000 in 2020 and averaged $448,167.
  • As far as peak fluctuations go, SELLAS Life Sciences Group's Non-Current Deferred Tax Liability grew by 9.31% in 2020, and later slumped by 89.03% in 2021.
  • SELLAS Life Sciences Group's Non-Current Deferred Tax Liability (Quarterly) stood at $1.3 million in 2019, then increased by 9.31% to $1.4 million in 2020, then tumbled by 89.03% to $152,000 in 2021.
  • Its Non-Current Deferred Tax Liability stands at $152,000 for Q4 2021, versus $239,000 for Q3 2021 and $239,000 for Q2 2021.